Gemcitabine-induced coronary vasospasm: A case report
Gemcitabine is a chemotherapy drug. It is a nucleoside analogue that is usually well tolerated by patients, with myelosuppression (especially thrombocytopenia) as dose-limiting side effect. Other mild to moderate side effects include alopecia, vomiting, nausea, rash, and fever. Coronary ischemia is...
Saved in:
Main Authors: | Mahmut Tuna Katırcıbaşı (Author), Aynur Eken (Author) |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ACUTE CORONARY SYNDROME DUE TO CORONARY VASOSPASM - CASE REPORT
by: S. D. Klimovskiy, et al.
Published: (2017) -
Coronary vasospasm as an etiology of recurrent ventricular fibrillation in the absence of coronary artery disease: a case report
by: Binita Bhandari, et al.
Published: (2021) -
Coronary vasospasm complicating atrial fibrillation ablation: a case report and review of the literature
by: Nirmal Guragai, et al.
Published: (2020) -
A new hope in the treatment of coronary vasospasm: bosentan
by: İlker Gül, et al.
Published: (2013) -
Recanalization of total aortoiliac occlusion via contralateral aortofemoral bypass graft
by: Mahmut Tuna Katırcıbaşı, et al.
Published: (2016)